Christopher Missling
Chief Executive Officer bei ANAVEX LIFE SCIENCES CORP.
Vermögen: 6 Mio $ am 31.03.2024
Profil
Christopher U.
Missling is currently the President, CEO, Secretary & Director at Anavex Life Sciences Corp.
He previously held positions as the Chief Financial Officer at ImmunoGen, Inc., CFO & Senior Vice President-Strategic Operations at Curis, Inc., Head-Financial Planning at Aventis, Inc., and Head-Healthcare Investment Banking at Brimberg & Co. He has a graduate and doctorate degree from Ludwig-Maximilians-Universität München, an MBA from WHU-Otto Beisheim School of Management, and another MBA from Kellogg School of Management.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 28.03.2024 | 1 250 210 ( 1,52% ) | 6 Mio $ | 31.03.2024 |
Aktive Positionen von Christopher Missling
| Unternehmen | Position | Beginn |
|---|---|---|
| ANAVEX LIFE SCIENCES CORP. | Chief Executive Officer | 05.07.2013 |
Ehemalige bekannte Positionen von Christopher Missling
| Unternehmen | Position | Ende |
|---|---|---|
| Aventis, Inc. | Corporate Officer/Principal | - |
| IMMUNOGEN, INC. | Director of Finance/CFO | - |
Brimberg & Co.
 Brimberg & Co. Investment Banks/BrokersFinance Brimberg & Co. LP is a broker/dealer headquartered in New York City. They provide a full array of trading and execution services for their clients. They do not provide any internal research. | Corporate Officer/Principal | - |
| CURIS, INC. | Director of Finance/CFO | - |
Ausbildung von Christopher Missling
| Ludwig-Maximilians-Universität München | Doctorate Degree |
| WHU-Otto Beisheim School of Management | Masters Business Admin |
| Kellogg School of Management | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| IMMUNOGEN, INC. | Health Technology |
| CURIS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
| Aventis, Inc. | |
Brimberg & Co.
Brimberg & Co. Investment Banks/BrokersFinance Brimberg & Co. LP is a broker/dealer headquartered in New York City. They provide a full array of trading and execution services for their clients. They do not provide any internal research. | Finance |
| Anavex Life Sciences Corp. |
